| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC3277 |
| Trial ID | NCT05652920 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Ori-C101 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC |
| Year | 2022 |
| Country | China |
| Company sponsor | OriCell Therapeutics Co., Ltd. |
| Other ID(s) | Ori-C101-P1 |
| Cohort 1 | |||||||
|
|||||||